ArticleJournal of clinical medicine2021

Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine.

Carlo Pescia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.